REPORT SCOPE
INTRODUCTION
STUDY GOALS AND OBJECTIVES
This market research report provides a comprehensive sizing, forecast, and analysis of the global market for “biobanking,” the storage of biological samples for the future.
The report will review global markets for biobank products and will forecast trends and sales in these markets through 2015. The report provides a range of information, from detailed analyses of how biobanks can lead to new products for specific diseases to overall industry trends. This information will allow the reader to evaluate and quantify the current market size for specific biobank services within the overall growing biomedical/pharmaceutical technology market.
Forecasts and trends have been developed from a variety of data, including industry sources, company publications, industry benchmarks, and other data sources. Major biobank repositories, technologies, geography, and factors influencing the demand for biobanks will be discussed. Consideration is given to an analysis of government issues versus the biotech/pharmaceutical industry markets.
REASONS FOR DOING THE STUDY
The biobanking market presents the largest of all opportunities in the area of new drug and treatment development for specific diseases. This study investigates one of the most important market drivers in the biotech/pharma area: the introduction to the market of a resource for investigating a variety of combined disease therapies. This is expected to contribute substantially to market growth through the forecast period. This report analyzes emerging biobanking markets, by specific disease segment and specific application. Continued worldwide growth is expected due the growing middle class in emerging countries such as India, China, Brazil, and Russia.
This report addresses the critically important topics of analyzing a changing market dynamic, the emerging players and technologies, strategies for accessing these emerging markets, and measurement and forecast of specific disease segments and geographies to allow for enhanced resource allocation.
SCOPE OF REPORT
Current and projected biobank product forecasts during the forecast period (2010 to 2015) are discussed. Biobanks are playing an important role in new drug development. New products approved by the FDA in 2009 and 2010 are covered, and those products expected to be approved within the forecast period are projected. Due to the timing of the release of this report, the figures for 2010 are estimated, except where actual results have been reported.
The report includes analysis of the leading competitors, as well as emerging companies in the current worldwide biobanking market. Profiles of the manufacturers of the leading products are analyzed, and their specific product strategies are outlined. This analysis also includes biotechnology companies that are using biobanks to develop new, novel products. This report looks at companies poised to introduce new products during the forecast period and discusses how these products may change the face of the competitive environment. This competitive environment is examined with a special focus on how developing products and technologies are influencing the current standard of patient care. Detailed profiles of the current market leaders and emerging companies are discussed in detail.
Market figures are based on revenues at the manufacturers’ level, and the base year for analysis and projection is 2010. Inflation is not calculated in the projection figures. Trends are assessed based on a number of parameters, including projected sales for existing products, new product introductions, expanded indications for existing products, and finally, for projected changes in the prevalence, diagnosis, and prescription rates for certain diseases.
Included in this report are an overview and forecast of the biobanking market by product, disease category, geographic region or country, and company for the period of 2009 to 2015. The worldwide market is analyzed and data are provided for each disease subsegment. Excluded from this report are over-the-counter (OTC) medications, and other consumables that do not require a physician’s prescription.
Sales figures are reported in U.S. dollars and in each case reflect currency fluctuations within the performance of revenue change. Revenue figures do not account for variation in local currencies.
All market share data presented is on a global basis, unless specifically noted.
INTENDED AUDIENCE
This report is an invaluable tool for business planners, acquisitions specialists, licensing strategists, product managers, market research analysts, investors, investor consultants, and anyone interested in the biobanking market, its products, industry participants, and future.
The importance of identifying overall market trends, product opportunities, emerging geographies, merger and acquisition opportunities, and insights that provide guidance for sales growth and business decisions for a variety of reasons, including the following:
- Established companies in the industry will benefit from the contents of this report, including corporate strategy, sales and marketing, business development, and R&D.
- Emerging biotechnology players must understand specific opportunities for out-licensing, originating from the differentiation of their biomarker product or technology as compared to leading, competitive, and emerging therapies. In addition, the market forecasts found in this study are supported in detail.
- Investment firms evaluating candidates for venture capital or investment in hedge funds will gain insights into the opportunity and risks encountered in the industry, with a product- and company-specific analysis.
- Equity analysts are provided with detailed forecasts for the next 5 years, substantiated by quantitative analysis that can support further analysis to product and company forecasts over the short and long run.
ANALYST CREDENTIALS
Jackson Highsmith is a life sciences research consultant with more than 16 years of research experience. Jackson has been consulting with specialty pharmaceuticals and large pharmaceutical industry players since 2007. Prior to that, he worked at a large research consultancy, where he focused on in-depth research; he also has worked at a large pharmaceutical company in a wide range of medical therapeutics in early- and mid-stage drug development.
METHODOLOGY AND INFORMATION SOURCES
Both primary and secondary research methodologies were used in preparing this report. In-depth interviews were conducted with leading experts in the field, including company executives, industry analysts, and leading medical practitioners.
The overall biobanking sector comprises a variety of fast growing and independent segments. For completeness, the current and forecasted markets comprise the total market for each respective segment. Within each subsection, there is a detailed forecast of each market driver or relevant area of growth.
The information used in preparing this report was obtained from emerging companies involved the biobanking industry, including their annual reports and 10-Ks. Information was also retrieved from articles published in medical journals such as the American Heart Journal, Circulation, Journal of BioBanks Pharmacology, Lancet, and others, governmental agencies such as the World Health Organization (WHO) and the National Heart, Lung and Blood Institute (NHLBI), and nonprofit organizations such as the American Heart Association. Population estimates are based on those reported by the U.S. Census Bureau’s international database.
Current and historical revenue figures for individual products have been sourced from company disclosures that exist in the public domain or from government sources.
BCC ONLINE SERVICES
BCC offers an online information retrieval service. BCC’s home page, located at www.bccresearch.com, enables readers to:
- Examine BCC’s complete catalog of Market Research Reports and place direct orders
- Subscribe to any of BCC’s many industry newsletters
- Read announcements of recently published reports and newly launched newsletters
- Register for BCC’s well–known conferences
- Request additional information on any BCC product
- Take advantage of special offers.
DISCLAIMER
The information developed in this report is intended to be as reliable as possible at the time of publication and of a professional nature. This information does not constitute managerial, legal, or accounting advice; nor should it serve as a corporate policy guide, laboratory manual, or an endorsement of any product, as much of the information is of a speculative in nature. The author assumes no responsibility for any loss or damage that might result from reliance on the reported information or from its use.
